1. Hench PS, Bauer W, Fletcher AA, et al.: Present status of the problem of “rheumatism”: review of recent American and English literature on “rheumatism” and arthritis (part 3). Ann Intern Med 1935, 8:1673–1697.
2. Katzung BG: Basic and Clinical Pharmacology. Edited by Katzung BG. Norwalk, CT: Appleton and Lange; 1995:536–559.
3. Martinon F, Petrilli V, Mayor A, et al.: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237–241.
4. • Terkeltaub B, Furst DE, Bennett K, et al.: Colchicine efficacy assessed by time to 50% reduction of pain is comparable in low dose and high dose regimens: secondary analyses of the AGREE trial. Arthritis Rheum 2009, 59:S1108. This study highlights needed information about colchicine dosing in acute gout.
5. Colcrys.com: Highlights of prescribing information. Available at http://www.colcrys.com/assets/pdf/COLCRYS_Full_Prescribing_Information.pdf . Accessed January 2010.